Childrens Hospital Colorado

The trials here

What the 19 trials at this site are about, from their registry records.

Conditions

• Childhood cancers5 trials
• Acute lymphoblastic leukaemia3 trials
• Asthma2 trials
• Epilepsy2 trials
• High blood pressure2 trials
• Pulmonary arterial hypertension2 trials
• Acute myeloid leukaemia1 trial
• Aplastic anaemia1 trial
• Chronic kidney disease1 trial
• Endometriosis1 trial
• Eosinophilic oesophagitis1 trial
• Hyperparathyroidism1 trial
• and 4 more

Phase

• Phase 36 trials
• Phase 25 trials
• Phase 12 trials
• Early phase 11 trial

Status

• Completed9 trials
• Active, not recruiting5 trials
• Recruiting3 trials
• Enrolling by invitation1 trial
• Terminated1 trial

Lead sponsor

• University of Colorado, Denver6 trials
• Amgen3 trials
• Novartis Pharmaceuticals3 trials
• Actelion2 trials
• Boston Children's Hospital2 trials
• and 3 more

Running trials

• Recruiting

  Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

  NCT06994845· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Claire Giachino

• Active, not recruiting

  A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

  NCT06693531· Regeneron Pharmaceuticals· Source

• Recruiting

  Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

  NCT06575738· Phase 1· University of Colorado, Denver· Source

  Contact: Jaime Moore, MD MPH

• Enrolling by invitation

  Antisense Oligonucleotide Treatment for PCARP Disease Due to Mutation in FLVCR1

  NCT06565572· Early phase 1· University of Colorado, Denver· Source

• Recruiting

  Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer

  NCT05524610· University of Colorado, Denver· Source

  Contact: Barbara Shepperd

• Active, not recruiting

  A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

  NCT04175600· Phase 3· Actelion· Source

• Active, not recruiting

  Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

  NCT03876769· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

  NCT04015141· Phase 2· Eisai Inc.· Source

• Active, not recruiting

  Preventing Asthma in High Risk Kids

  NCT02570984· Phase 2· Boston Children's Hospital· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• IgA nephropathy1 recruiting
• Obesity1 recruiting
• Retinitis pigmentosa1 recruiting

Closed trials

• Completed

  High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology

  NCT04940468· University of Colorado, Denver· Source

• Completed

  Integrative Health Interventions in Symptom Management of Pediatric Patients

  NCT05594693· University of Colorado, Denver· Source

• Completed

  Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

  NCT05323734· Phase 3· Marinus Pharmaceuticals· Source

• Completed

  Treatment Phenotypes for Adolescents With Asthma

  NCT04228107· University of Colorado, Denver· Source

• Completed

  Cabergoline for the Treatment of Chronic Pain Due to Endometriosis

  NCT03928288· Phase 2· Boston Children's Hospital· Source

• Completed

  Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine

  NCT03832998· Phase 3· Amgen· Source

• Recruiting

  A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

  NCT03633708· Phase 3· Amgen· Source

• Completed

  A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

  NCT02932410· Phase 3· Actelion· Source

• Completed

  A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

  NCT03025698· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

  NCT02303821· Phase 1· Amgen· Source